MHRA seizes $1.5m worth of unlicensed ED drugs
Around 500,000 doses of unlicensed erectile dysfunction (ED) drugs have been seized by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Archives for October 21, 2015
Biogen axing 11% of workforce in plan to save $250m annually
Biogen will cut around 530 US jobs as part of a restructuring plan it hopes will save $250m (€221m) in operating costs annually.
Intertek's CA bioanalytical lab expansion latest response to biopharma demand
An expanded San Diego facility will support demand for preclinical and clinical development services driven by the growth in the antibody and biosimilar sector, Intertek says.
CPhI Worldwide 2015
Rush to acquire ex-pharma sites means survival of the biggest for CMOs
As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say experts.
AstraZeneca opens $224m Russian plant for local production
AstraZeneca has opened a $224m manufacturing site in Russia it says is the largest foreign pharma investment in the country.